Fidelity Asian Values PLC

Tim Scholefield ^{1, 2, 3} is a non-executive Director of BMO Capital and Income Investment Trust PLC, Jupiter Unit Trust Manager Ltd and Standard Life UK Smaller Companies PLC.  He is Chairman of City Merchants High Yield Trust Ltd and a member of the Investment Management Certificate Panel. He has had over thirty years’ experience in investment management, latterly as Head of Equities at Baring Asset Management until April 2014.

Appointed as Director on 30 September 2015.
Appointed as Senior Independent Director on 22 April 2020.
Stood down as Senior Independent Director on 22 April 2021

All the Directors are non-executive directors and are also independent.

¹ Members of the Management Engagement Committee
² Members of the Nomination Committee
³ Members of the Audit Committee.

Kate Bolsover ^1,2 serves as a Director of TR Property Investment Trust PLC, Baillie Gifford & Company Limited  and is Chairman of Invesco Enhanced Investment Trust. 

She worked for Cazenove Group plc and J.P. Morgan Cazenove between 1995 and 2005 where she was managing director of the mutual fund business, and latterly director of Corporate Communications. Prior to this, her work involved business development and mutual funds experience covering countries in the Far East.  

Appointed as Director on 1 January 2010.
Appointed Chairman on 9 December 2014.

All the Directors are non-executive directors and are all independent.

¹ Chairman of the Nomination Committee
² Attendee of the Audit Committee

Hussein Barma^1,2,3 is a non-executive Director, member of the Audit Committee and Chair of the Remuneration Committees of Atalaya Mining plc (which is listed on the Main Market of the London Stock Exchange). He is an independent Governor and Deputy Chair of the Audit Committee of the University of the Arts London and a Member of the Finance Committee for the Oxford Centre for Islamic Studies. Between 1998 to 2014, he was the UK-based Chief Financial Officer of Antofagasta plc. His earlier career was in professional services and academia and he held positions at the Financial Reporting Council and Modern Art Oxford. He is a qualified Barrister and Chartered Accountant and holds a doctorate in corporate law.

Appointed as Director and Chairman of Audit Committee on 24 November 2022

All the Directors are non-executive directors and are also independent

¹ Member of the Management Engagement Committee
² Member of the Nomination Committee
³ Chair of the Audit Committee

Michael Warren ^{1,2, 3} is a non-executive Director of Henderson Smaller Companies Investment Trust plc, Carrington Investments, Rathbones Asset Management Ltd and EdenTree Investment Management. He is a past non-executive Director of Liontrust Panthera, Alquity Investment Management Ltd and Vindependents, and a past adviser to Gresham House Asset Management. He worked for Thames River Capital from 2007 until 2012 as Investment Director. Prior to that he worked at HSBC Investments, where he was responsible for Institutional and Retail distribution, and before that at Deutsche Asset Management, where he was a main board member. Latterly, he served as Managing Director of the UK mutual fund business, DWS.

Appointed as Director on 29 September 2014
Stepped down as Chairman of the Management Engagement Committee on 3 April 2024

All the Directors are non-executive directors and are also independent.

¹ Member of the Management Engagement Committee
² Member of the Nomination Committee
³ Member of the Audit Committee

Clare Brady ^{1, 2,}  is a chartered governance professional with 35 years experience in banking and financial services. Clare is a non-executive director of M&G Group Limited, M&G Investment Management Limited and M&G Alternatives Investment Management Limited. She chairs the Audit Committee and is a member of the Risk Committee and the Conflicts Committee. Clare is also a non-executive director of Bellevue Healthcare Trust plc, and a non-executive director of The Golden Charter Trust Limited, a member of its Audit and Risk Committee and Chairs its Nominations and Remuneration Committee.

Clare was a non-executive director of Credit Suisse until its recent merger with UBS. In her executive career, she was a Director of the International Monetary Fund (IMF) and prior to that, the Auditor General at the World Bank, based in Washington D.C. Previously, Clare headed audit and compliance functions at the Bank of England, Barclays Capital, HSBC and Deutsche Bank.

Appointed as Director on 1 August 2019.
Appointed Chairman on 29 November 2023.

All the Directors are non-executive directors and are also independent.

¹ Members of the Management Engagement Committee
² Members of the Nomination Committee

Sally Macdonald ^{1, 2, 3} is a non-executive Director of JP Morgan Japanese Investment Trust plc and Evelyn Partners Fund Solutions Ltd. She was Head of Asian Equities at Marlborough Fund Managers. She has over 40 years’ experience of financial markets, which includes more than 30 years as an Asian fund manager. She has previously run the Asian desks for Sanwa, Lazard Brothers Asset Management, Canada Life, Morley (Aviva) and City of London Investment Group.

Appointed as Director on 1 January 2022
Appointed as Management Engagement Committee Chairman on 3 April 2024
 

All the Directors are non-executive directors and are also independent

¹ Chairman of the Management Engagement Committee
² Member of the Nomination Committee
³ Member of the Audit Committee

Matthew Sutherland ^{1, 2, 3} has 32 years’ experience of working in financial markets, primarily as an equity analyst and head of research, of which the last twenty-four were spent living in Asia covering Asian markets. From 2006 to 2016, he worked for Fidelity International, running its highly regarded Asian equity research team of over 70 analysts from its Hong Kong and Tokyo offices. He was also responsible for hiring and training analysts in India, China, Korea, Hong Kong, Singapore, Japan and Australia which included coverage of all the Asian stock markets. Prior to joining Fidelity, he was Country Head for HSBC Securities in Taiwan and worked for BNP Paribas in Manila.

Appointed as Director on 1 January 2022
Appointed as Senior Independent Director on 29 November 2023.

All the Directors are non-executive directors and are also independent.

¹ Member of the Management Engagement Committee
² Member of the Nomination Committee
³ Member of the Audit Committe

Lucy Costa Duarte ^1,2,3 is a non-executive director of MIGO Opportunities Trust plc, Investment Director for International Biotechnology Trust plc (IBT) at Schroders and an AIC Marketing Ambassador. Lucy’s expertise is in marketing investment trusts to retail investors, private wealth managers and institutions. In her earlier career, Lucy was a director at Citigroup, heading the emerging markets ECM team in London. Lucy left Citigroup in 2007 and took a career break, before starting work with IBT at SV Health Investors in 2016 and moving with IBT to Schroders in 2023. 
 
Appointed as Director with effect from 1 June 2024. 

¹ Member of the Management Engagement Committee
² Member of the Nomination Committee
³ Member of the Audit Committee